HuMax-CD4 in Non-Cutaneous T-Cell Lymphoma

Clinical trial NCT00877656 · COMPLETED

Trial details

NCT number: NCT00877656
Sponsor: Emergent BioSolutions
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

T Cell Lymphoma

Start date: 2005-08-01
Primary completion: 2006-01-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.